Roundhill Space and Technology ETF (MARS)
Live price chart, market sentiment, and community perspectives for Roundhill Space and Technology ETF (CBOE: MARS).
Live price chart, market sentiment, and community perspectives for Roundhill Space and Technology ETF (CBOE: MARS).
Option volume on MARS indicates large block hedging by prime desks. Downside asymmetry is expanding.
On our desk, we are tracking the post-launch lifecycle of MARS very closely. Trading around $27.01 with an AUM hovering near $50 million and an expense ratio of 0.75%, this actively managed fund gives us a clean proxy for pure-play space infrastructure. Sentiment took a hit during the June 2026 U.S. space stock slump following SpaceX's market debut, but the addition of high-profile names like SpaceX, Rocket Lab, and AST SpaceMobile keeps the thematic thesis intact. Investors need to stomach high valuation multiples and negative profitability metrics like a -128.00 P/E ratio, but the structural growth narrative through 2035 remains a massive talking point.
Looking at the fundamental risks outlined in the prospectus, I remind our team that space and technology companies are heavily tethered to government contracting cycles, cybersecurity threats, and supply chain bottlenecks. MARS is a non-diversified fund with 32 holdings, meaning concentration risk is very real. While reusable launch tech and lower deployment costs are easing capital expenditure fears, any shifts in federal space budgets or defense spending will directly ripple through its top industrials and communication service allocations.
As a quant evaluating active thematic ETFs, my protocol focuses on liquidity, bid-ask spreads, and underlying weight distributions. MARS exhibits a daily average volume of roughly 37.8K shares with top holdings heavily concentrated in the likes of Rocket Lab, AST SpaceMobile, and SpaceX. When modeling volatility vectors for this asset class, we have to account for the beta of speculative space equity and the risk-off behavior observed when broader tech rallies cool. Keep a close eye on the fund's 52-week range of $22.29 to $45.92 to map out tactical entry bands.
Explore plasma cleansing, somatic organ swaps, and BCI.